中西医结合心血管病电子杂志
中西醫結閤心血管病電子雜誌
중서의결합심혈관병전자잡지
Cardiovascular Disease Journal of Integrated Traditional Chinese and Western Medicine (Electronic)
2014年
7期
119-119,121
,共2页
米力农%丹参川穹嗪%肺源性心脏病%心力衰竭%疗效观察与评价
米力農%丹參川穹嗪%肺源性心髒病%心力衰竭%療效觀察與評價
미력농%단삼천궁진%폐원성심장병%심력쇠갈%료효관찰여평개
Milrinone%Danshen Ligustrazin%Pulmonary Heart Disease%Heart Failure%Curative Effect Observation And Evaluation
目的:观察米力农联合丹参川穹嗪注射液治疗肺源性心脏病心力衰竭的治疗效果,并作出客观评价。方法选取近一年来在本院接受治疗的46例肺源性心脏病合并心力衰竭患者为本次的观察对象,根据随机分配对比原则,将患者分成人数均等的两组进行比较,其中接受常规综合治疗的为对照组,在此基础上加用米力农联合丹参川穹嗪注射液治疗的作为观察组,分别观察两组患者治疗情况并进行比较。结果经治疗两组患者病情均得到不同程度的缓解,但通过对整体治疗效果的评价,观察组治疗有效性显著优于对照组,且差别具有统计学意义(P<0.05)。结论米力农联合丹参川穹嗪治疗肺源性心脏病合并心力衰竭比常规综合治疗具有更高的安全性及有效性,临床治疗用药选择时应尤为注意。
目的:觀察米力農聯閤丹參川穹嗪註射液治療肺源性心髒病心力衰竭的治療效果,併作齣客觀評價。方法選取近一年來在本院接受治療的46例肺源性心髒病閤併心力衰竭患者為本次的觀察對象,根據隨機分配對比原則,將患者分成人數均等的兩組進行比較,其中接受常規綜閤治療的為對照組,在此基礎上加用米力農聯閤丹參川穹嗪註射液治療的作為觀察組,分彆觀察兩組患者治療情況併進行比較。結果經治療兩組患者病情均得到不同程度的緩解,但通過對整體治療效果的評價,觀察組治療有效性顯著優于對照組,且差彆具有統計學意義(P<0.05)。結論米力農聯閤丹參川穹嗪治療肺源性心髒病閤併心力衰竭比常規綜閤治療具有更高的安全性及有效性,臨床治療用藥選擇時應尤為註意。
목적:관찰미력농연합단삼천궁진주사액치료폐원성심장병심력쇠갈적치료효과,병작출객관평개。방법선취근일년래재본원접수치료적46례폐원성심장병합병심력쇠갈환자위본차적관찰대상,근거수궤분배대비원칙,장환자분성인수균등적량조진행비교,기중접수상규종합치료적위대조조,재차기출상가용미력농연합단삼천궁진주사액치료적작위관찰조,분별관찰량조환자치료정황병진행비교。결과경치료량조환자병정균득도불동정도적완해,단통과대정체치료효과적평개,관찰조치료유효성현저우우대조조,차차별구유통계학의의(P<0.05)。결론미력농연합단삼천궁진치료폐원성심장병합병심력쇠갈비상규종합치료구유경고적안전성급유효성,림상치료용약선택시응우위주의。
Objective To observe the therapeutic effect of milrinone combined with Danshen Ligustrazin injection in the treatment of heart failure of pul-monary heart disease,and make an objective evaluation. Methods It was selected nearly a year to receive treatment in our hospital 46 cases of pulmonary heart disease complicated with heart failure patients as the observation object,according to the random distribution of the contrast principle,the patients were divided into equal number of two groups were compared,which received conventional therapy as the control group,on the basis of treated with milrinone combined with Danshen Ligustrazin injection as the observation group,the two groups were observed and compared with the treatment of patients. Results The treatment group two patients were reduced in different degrees,but throμgh the overall therapeutic effect evaluation,observation group treatment effectiveness is significantly bet-ter than the control group,and with statistically significant difference(P<0. 05 ). Conclusion Milrinone combined with Danshen Ligustrazin for treatment of pulmonary heart disease complicated with heart failure is more safe and effective than the conventional therapy,It should be especially paid attention to the clini-cal treatment choice.